Sartorius market cap is €36.6 b, and annual revenue was €2.34 b in FY 2020

Sartorius Gross profit (Q2, 2021)455.4 M

Sartorius Gross profit margin (Q2, 2021), %54.3%

Sartorius Net income (Q2, 2021)145.9 M

Sartorius EBIT (Q2, 2021)230.3 M

Sartorius Cash, 30-Jun-2021423.6 M

Sartorius EV38.3 B

Sartorius revenue was €2.34 b in FY, 2020 which is a 27.8% year over year increase from the previous period.

Sartorius revenue breakdown by business segment: 23.7% from Lab Products and Services and 76.3% from Bioprocess Solutions

Sartorius revenue breakdown by geographic segment: 25.2% from Asia Pacific, 34.8% from Americas and 40.0% from EMEA

EUR | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|

## Revenue | 1.6b | 1.8b | 2.3b |

| 11% | 17% | 28% |

## Cost of goods sold | 762.4m | 885.8m | 1.1b |

## Gross profit | 803.6m | 941.2m | 1.2b |

| 51% | 52% | 52% |

## Sales and marketing expense | 329.8m | 369.7m | 438.7m |

## R&D expense | 78.2m | 95.6m | 108.4m |

## General and administrative expense | 94.2m | 107.2m | 125.9m |

## Operating expense total | 505.0m | 605.5m | 749.7m |

## EBIT | 298.6m | 335.7m | 456.1m |

| 19% | 18% | 20% |

## Interest expense | 13.4m | 14.7m | 21.7m |

## Interest income | 499.0k | 341.0k | 414.0k |

## Pre tax profit | 270.7m | 303.2m | 446.7m |

## Income tax expense | 73.2m | 84.4m | 125.2m |

## Net Income | 197.5m | 218.7m | 321.5m |

## EPS | 2.1 | 2.3 | 3.3 |

EUR | Q1, 2019 | Q3, 2019 | Q2, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 |
---|---|---|---|---|---|---|---|---|

## Revenue | 435.7m | 461.2m | 459.0m | 509.9m | 546.9m | 623.2m | 791.1m | 838.1m |

## Cost of goods sold | 212.6m | 224.2m | 222.9m | 245.3m | 262.3m | 294.3m | 374.1m | 382.7m |

## Gross profit | 223.1m | 237.0m | 236.1m | 264.6m | 284.6m | 328.9m | 417.0m | 455.4m |

| 51% | 51% | 51% | 52% | 52% | 53% | 53% | 54% |

## Sales and marketing expense | 89.3m | 91.9m | 93.3m | 102.2m | 108.3m | 110.8m | 129.0m | 142.2m |

## R&D expense | 22.6m | 23.1m | 22.7m | 25.6m | 24.3m | 28.0m | 32.2m | 34.2m |

## General and administrative expense | 27.3m | 27.8m | 25.0m | 30.0m | 30.7m | 31.0m | 37.0m | 42.0m |

## Operating expense total | 143.5m | 154.1m | 149.1m | 174.7m | 185.2m | 185.3m | 335.2m | 225.1m |

## EBIT | 79.6m | 82.8m | 8.7m | 89.9m | 99.5m | 143.5m | 205.1m | 230.3m |

| 18% | 18% | 2% | 18% | 18% | 23% | 26% | 27% |

## Pre tax profit | 72.2m | 74.8m | 84.5m | 90.3m | 78.8m | 135.5m | 174.3m | 212.4m |

## Income tax expense | 19.5m | 20.2m | 22.8m | 24.4m | 26.3m | 40.7m | 60.1m | 66.4m |

## Net Income | 52.7m | 54.6m | 61.7m | 65.9m | 52.5m | 94.9m | 114.2m | 145.9m |

## EPS | 0.6 | 0.6 | 0.7 | 0.7 | 0.5 | 1.0 | 1.2 | 1.6 |

EUR | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|

## Cash | 45.2m | 53.9m | 203.4m |

## Accounts Receivable | 307.4m | 302.3m | 314.3m |

## Inventories | 321.7m | 411.8m | 558.6m |

## Current Assets | 753.9m | 848.6m | 1.2b |

## PP&E | 659.6m | 829.6m | 971.2m |

## Goodwill | 662.2m | 705.0m | 1.4b |

## Total Assets | 2.5b | 2.8b | 4.7b |

## Accounts Payable | 173.5m | 224.1m | 330.7m |

## Short-term debt | 110.0m | 187.6m | 195.3m |

## Current Liabilities | 480.7m | 661.6m | 870.9m |

## Long-term debt | 894.6m | 877.6m | 1.9b |

## Non-Current Liabilities | 1.1b | 1.1b | 2.4b |

## Total Debt | 904.6m | 1.1b | 2.1b |

## Common Stock | 68.4m | 68.4m | 68.4m |

## Retained Earnings | 639.8m | 710.1m | 1.0b |

## Total Equity | 973.4m | 1.1b | 1.4b |

## Debt to Equity Ratio | 0.9 x | 1 x | 1.5 x |

## Debt to Assets Ratio | 0.4 x | 0.4 x | 0.4 x |

## Financial Leverage | 2.6 x | 2.6 x | 3.3 x |

EUR | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|

## Depreciation and Amortization | 113.4m | 132.6m | 180.6m |

## Accounts Receivable | (44.7m) | 18.2m | (59.3m) |

## Inventories | (73.7m) | (77.2m) | (114.8m) |

## Cash From Operating Activities | 244.5m | 377.2m | 511.5m |

## Capital Expenditures | (233.2m) | (225.6m) | (240.3m) |

## Cash From Investing Activities | (242.5m) | (269.2m) | (1.3b) |

## Long-term Borrowings | (41.2m) | (185.8m) | (196.9m) |

## Dividends Paid | (46.2m) | (56.9m) | (33.1m) |

## Cash From Financing Activities | (16.7m) | (101.5m) | 907.5m |

## Net Change in Cash | (14.7m) | 6.4m | 148.5m |

## Income Taxes Paid | 69.6m | 69.3m | 120.1m |

## Free Cash Flow | 11.3m | 151.6m | 271.3m |

EUR | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 |
---|---|---|---|---|---|---|---|---|

## Depreciation and Amortization | 29.5m | 60.8m | 93.8m | 35.8m | 80.4m | 127.9m | 53.4m | 109.2 |

## Accounts Receivable | (6.4m) | (23.3m) | (25.8m) | 17.1m | (12.9m) | (34.8m) | (51.4m) | (60.1) |

## Inventories | (20.3m) | (45.5m) | (71.2m) | (16.8m) | (58.1m) | (983.3m) | (54.3m) | (123.0) |

## Cash From Operating Activities | 105.9m | 165.1m | 254.1m | 113.9m | 215.4m | 380.0m | 228.9m | 440.7 |

## Capital Expenditures | (56.1m) | (114.7m) | (169.0m) | (44.8m) | (89.6m) | (134.8m) | (80.8m) | (147.2) |

## Cash From Investing Activities | (55.0m) | (116.0m) | (175.6m) | (46.1m) | (93.3m) | (140.4m) | (90.4m) | (160.0) |

## Long-term Borrowings | (43.3m) | (41.3m) | (57.6m) | (91.1m) | (209.1m) | (209.1m) | (115.1m) | (197.0) |

## Dividends Paid | (56.6m) | (57.0m) | (800.0k) | (33.2m) | (64.6m) | (65.7) | ||

## Cash From Financing Activities | (46.8m) | (41.9m) | (61.9m) | 2.2m | 769.8m | 950.1m | 16.8m | (61.0) |

## Net Change in Cash | 4.1m | 7.2m | 16.7m | 70.1m | 135.7m | 419.1m | 155.2m | 219.7 |

## Income Taxes Paid | 7.4m | 33.9m | 47.8m | 17.7m | 44.2m | 73.5m | 32.8m | 94.3 |

## Free Cash Flow | 49.8m | 50.4m | 85.1m | 69.1m | 125.8m | 245.2m | 148.1m | 293.5 |

EUR | FY, 2018 |
---|---|

## Revenue/Employee | 199.1k |

## Debt/Equity | 0.9 x |

## Debt/Assets | 0.4 x |

## Financial Leverage | 2.6 x |

FY, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | FY, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | FY, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Nov, 2020 | FY, 2020 | Q1, 2021 | Q2, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|

## Order Intake | €1.5 b | €404.8 m | €402.8 m | €407.6 m | €1.66 b | €482.8 m | €491.5 m | €460.7 m | €1.94 b | €629.4 m | €615.4 m | €711.7 m | €2.84 b | €1.14 b | €1.04 b | |

## Order Intake (Bioprocess Solutions) | €1.09 b | €295.1 m | €299.4 m | €307.3 m | €1.23 b | €366 m | €380.3 m | €353.7 m | €1.48 b | €506.2 m | €478.8 m | €561.9 m | €2.24 b | €953 m | €850.3 m | |

## Order Intake (Lab Products & Services) | €410.1 m | €109.6 m | €103.4 m | €100.4 m | €428.8 m | €116.8 m | €111.1 m | €107.1 m | €460.3 m | €123.3 m | €136.6 m | €149.8 m | €598.2 m | €185.6 m | €189.9 m | |

## Patent Applications (US) | 81 | |||||||||||||||

## Patents (US) | 126 |

FY, 2020 | |
---|---|

## Total Greenhouse Gas Emissions | 43.16 k metric tons of carbon dioxide equivalent |

## Greenhouse Gas Emissions (Scope 2) | 27.88 k metric tons of carbon dioxide equivalent |

## Greenhouse Gas Emissions (Scope 1) | 15.28 k metric tons of carbon dioxide equivalent |

## Energy Consumption (Other) | 5.67 k MWh |

## Energy Consumption (Electricity from Public Grid) | 70.95 k MWh |

## Energy Consumption (Direct) | 55.44 k MWh |

## Energy Consumption | 132.07 k MWh |

FY, 2020 | FY, 2019 | FY, 2018 | |
---|---|---|---|

Administration | 10% | 10% | 9.7% |

Research and Development | 8.6% | 8.7% | 8.4% |

Sales and Marketing | 23.9% | 24.9% | 23.9% |

Production | 57.5% | 56.4% | 57.9% |